Estudiantes de minorías analizan datos de COVID sobre disparidades raciales
By Esther Landhuis
August 13, 2020
KFF Health News Original
Los datos para abordar las brechas raciales en la atención en las comunidades más necesitadas, y sus resultados, han sido escasos durante la pandemia.
Trump Tells Supporters ‘It’s A Great Vaccine, It’s A Safe Vaccine’
March 17, 2021
Morning Briefing
Former President Donald Trump backed the coronavirus vaccines developed during his administration, as concern grows over hesitancy among Republicans.
Unclassified Report Of US Covid Origins Probe Expected To Be Released
August 26, 2021
Morning Briefing
President Joe Biden was briefed yesterday by intelligence officials on the 90-day review he had ordered. Before anything has even been released to the public, China criticized the investigation as “propaganda.” Meanwhile, a group of scientists warn that time is running out to get the necessary data to truly pinpoint the source of the coronavirus that sparked the global pandemic.
‘Why Do We Always Get Hit First?’ Proposed Budget Cuts Target Vulnerable Californians
By Samantha Young
June 1, 2020
KFF Health News Original
Safety-net health care programs that keep low-income Californians out of nursing homes are on the chopping block as Gov. Gavin Newsom and state lawmakers attempt to plug a massive budget deficit caused by the COVID-19 emergency.
As Covid Variants Spread, CDC Director Warns Of ‘Pandemic Fatigue’
February 19, 2021
Morning Briefing
Coronavirus cases are trending down, but new variants, complications and people tiring of pandemic restrictions concern scientists and the CDC.
Primer médico de ER en EE.UU. que muere en el frente de batalla contra COVID-19
By Alastair Gee, The Guardian
April 9, 2020
KFF Health News Original
The Guardian y Kaiser Health News están lanzando un nuevo proyecto, “Lost on the Frontline” (Perdidos en el Frente), para monitorear estos casos, y contar sus historias.
Using Stories To Mentally Survive As A COVID-19 Clinician
By Stephanie Stephens
June 11, 2020
KFF Health News Original
The practice of narrative medicine helps health care professionals hear the life stories behind a patient’s immediate complaints. Some doctors are finding that these skills also provide an alcove of needed reflection amid the pandemonium of COVID-19.
Pressure Rises For ‘Transparent’ Investigation Into Covid’s Origins
May 26, 2021
Morning Briefing
Speaking at the World Health Assembly, Health and Human Services Secretary Xavier Becerra pushed for a “transparent, science-based” follow-up investigation into where the coronavirus pandemic originated. Reports note the matter is causing political turmoil.
Teachers Now Eligible For The Shot In Every State
March 9, 2021
Morning Briefing
Every state has now prioritized K-12 educators to receive the coronavirus vaccine. News outlets also report on hesitant groups.
Biden Administration: Hope Or More Mobilization On Covid?
April 1, 2021
Morning Briefing
A surge in covid cases presents the Biden Administration with a policy dilemma: Emphasize how close nation is to ending the epidemic or stress the immediate dangers of the coronavirus and its variants.
Big Study Confirms That Coronavirus Antibodies Last At Least 6 Months
February 3, 2021
Morning Briefing
Three months after a natural infection, 99% of the 20,000 study participants retained antibodies. After six months, 88% had antibodies. The results follow several smaller studies with similar results. However, it’s still unclear how long antibodies last after receiving a covid vaccine.
Cruise Ships Will Go On Test Runs
May 6, 2021
Morning Briefing
Each practice cruise will operate in U.S. waters and last two to seven days. In other travel news: Scammers at an Indonesian airport reused coronavirus testing swabs on as many as 9,000 people.
Allergic Reactions To COVID Vaccine Investigated
December 21, 2020
Morning Briefing
Scientists are examining a few severe allergic reactions to the coronavirus vaccine.
FDA Approves Eli Lilly’s Antibody Cocktail For Emergency Use
February 10, 2021
Morning Briefing
Eli Lilly’s antibody combination drug is the second such therapy cleared by the FDA to treat mild and moderate coronavirus cases.
Más pruebas para COVID, pero esperas demasiado largas por los resultados
By Phil Galewitz
July 9, 2020
KFF Health News Original
Con la demanda en alza, los resultados de las pruebas para COVID-19 están tardando hasta 10 días, lo que dificulta los esfuerzos de salud pública para frenar la propagación.
‘I Wasn’t Eating’: Senior Twin Sisters Battle Pandemic Anxiety Together
By Cara Anthony
April 16, 2020
KFF Health News Original
Twins Edna Mayes and Ethel Sylvester, 92, are relying on each other through the pandemic, in which one of the hidden dangers is to their mental health.
At A Time Of Great Need, Public Health Lacks ‘Lobbying Muscle’
By Angela Hart
June 15, 2020
KFF Health News Original
Public health officials are asking for more money in California’s state budget. But unlike some rich and powerful health care interests, they don’t have an army of lobbyists to curry favor with lawmakers.
El Congreso dijo que los tests de COVID-19 debían ser gratuitos, pero ¿quién paga?
By Blake Farmer, Nashville Public Radio
May 22, 2020
KFF Health News Original
A fines de marzo, el Congreso aprobó dos leyes, que esencialmente establecieron no solo que las pruebas para COVID tenían que estar cubiertas, sino que los pacientes no debían pagar un centavo.
Longer Looks: Interesting Reads You Might Have Missed
March 26, 2021
Morning Briefing
Each week, KHN finds longer stories for you to sit back and enjoy. This week’s selections include stories on covid treatments, vaccinations and traveling in the age of the coronavirus.
Coronavirus Antibodies Can Be Tricky
October 28, 2020
Morning Briefing
In some people, the antibodies have attacked their immune systems instead of the virus. And some experts, responding to a large study that suggested immunity may not last very long, say fears are overblown because it’s normal for levels of antibodies to drop after the body clears an infection.
